Back

Can we avoid randomized clinical trials for new CV drugs? .

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Current controversies in clinical trial design Cardiovascular Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Ms Karen Pieper

Thrombosis Research Institute, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Critical issues in endpoint definition.
Professor J. Tijssen (Amsterdam, NL)
Slides Video
Presentation thumbnail
Lost to follow-up in cardiovascular trials.
Associate Professor V. Serebruany (Baltimore, US)
Slides Video
Presentation thumbnail
Current controversies in clinical trial design - Panel discussion.
Video

Access the full session

Session thumbnail
Current controversies in clinical trial design

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on pharmacotherapy for acute coronary syndromes
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
thumbnail
Congress Presentation
Medical treatment works! Contemporary implementation into clinical practice

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources